Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer.
Bari E, Ferrera F, Altosole T, Perteghella S, Mauri P, Rossi R, Passignani G, Mastracci L, Galati M, Astone GI, Mastrogiacomo M, Castagnola P, Fenoglio D, Di Silvestre D, Torre ML, Filaci G. Bari E, et al. Among authors: ferrera f. J Immunother Cancer. 2023 Jan;11(1):e005916. doi: 10.1136/jitc-2022-005916. J Immunother Cancer. 2023. PMID: 36697251 Free PMC article.
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.
Filaci G, Fenoglio D, Nolè F, Zanardi E, Tomasello L, Aglietta M, Del Conte G, Carles J, Morales-Barrera R, Guglielmini P, Scagliotti G, Signori A, Parodi A, Kalli F, Astone G, Ferrera F, Altosole T, Lamperti G, Criscuolo D, Gianese F, Boccardo F. Filaci G, et al. Among authors: ferrera f. Cancer Immunol Immunother. 2021 Dec;70(12):3679-3692. doi: 10.1007/s00262-021-03024-0. Epub 2021 Aug 5. Cancer Immunol Immunother. 2021. PMID: 34351436 Free PMC article. Clinical Trial.
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.
Parodi A, Battaglia F, Kalli F, Ferrera F, Conteduca G, Tardito S, Stringara S, Ivaldi F, Negrini S, Borgonovo G, Simonato A, Traverso P, Carmignani G, Fenoglio D, Filaci G. Parodi A, et al. Among authors: ferrera f. Cancer Immunol Immunother. 2013 May;62(5):851-62. doi: 10.1007/s00262-013-1392-z. Epub 2013 Jan 29. Cancer Immunol Immunother. 2013. PMID: 23359087 Free PMC article.
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
Fenoglio D, Traverso P, Parodi A, Tomasello L, Negrini S, Kalli F, Battaglia F, Ferrera F, Sciallero S, Murdaca G, Setti M, Sobrero A, Boccardo F, Cittadini G, Puppo F, Criscuolo D, Carmignani G, Indiveri F, Filaci G. Fenoglio D, et al. Among authors: ferrera f. Cancer Immunol Immunother. 2013 Jun;62(6):1041-52. doi: 10.1007/s00262-013-1415-9. Epub 2013 Apr 17. Cancer Immunol Immunother. 2013. PMID: 23591981 Free PMC article.
AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma.
Conteduca G, Fenoglio D, Parodi A, Battaglia F, Kalli F, Negrini S, Tardito S, Ferrera F, Salis A, Millo E, Pasquale G, Barra G, Damonte G, Indiveri F, Ferrone S, Filaci G. Conteduca G, et al. Among authors: ferrera f. Oncotarget. 2016 Sep 20;7(38):60872-60884. doi: 10.18632/oncotarget.11506. Oncotarget. 2016. PMID: 27563821 Free PMC article.
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer.
Filaci G, Fravega M, Setti M, Traverso P, Millo E, Fenoglio D, Negrini S, Ferrera F, Romagnoli A, Basso M, Contini P, Rizzi M, Ghio M, Benatti U, Damonte G, Ravetti JL, Carmignani G, Zanetti M, Indiveri F. Filaci G, et al. Among authors: ferrera f. Blood. 2006 Feb 15;107(4):1505-12. doi: 10.1182/blood-2005-01-0258. Epub 2005 Oct 25. Blood. 2006. PMID: 16249379 Free article.
Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one.
Fenoglio D, Parodi A, Lavieri R, Kalli F, Ferrera F, Tagliamacco A, Guastalla A, Lamperti MG, Giacomini M, Filaci G. Fenoglio D, et al. Among authors: ferrera f. Hum Vaccin Immunother. 2015;11(4):838-50. doi: 10.1080/21645515.2015.1012032. Hum Vaccin Immunother. 2015. PMID: 25714118 Free PMC article. Clinical Trial.
44 results